Glympse Bio
  • About
  • Technology
  • Pipeline
  • News & Events
  • Careers
  • Contact
  • Menu Menu

Technology

Revolutionary Technology for Diagnosing and Monitoring Disease

To understand how Glympse noninvasively measures protein activity to diagnose and monitor disease, view this animation.

How Our Technology Works

Disease-Specific Protease Activity

Specific proteases, or enzymes that break down proteins, are fundamental to specific diseases. Changes in protease activity can be correlated to disease progression.

Measuring Proteases with Tunable Biosensors

Glympse’s biosensors include peptide molecules that are specifically cleaved by disease-specific proteases. By measuring this interaction, we can determine the activity of each protease.

Clinically Actionable Results

Glympse uses a proprietary machine learning algorithm to translate disease-specific protease activity data into clinically actionable information. This allows accurate, real-time tracking of disease progression.

Noninvasive Diagnosis & Monitoring

The lead indication for the platform is NASH, which is currently diagnosed through an invasive liver biopsy procedure. The biosensors can accurately measure liver protease activity from a simple, noninvasive blood draw.

Explore our technology in depth.

Read Our Publications

35 Cambridgepark Drive
Suite 100
Cambridge, MA 02140

info@glympsebio.com

  • About
  • Technology
  • Pipeline
  • News & Events
  • Careers
  • Contact

© 2022 Glympse Bio. All rights reserved.

Terms of Use | Privacy Policy | Other Policies

Design and development by RainCastle Communications.

Images by Liz Linder Photography.